메뉴 건너뛰기




Volumn 3, Issue 3, 2018, Pages 252-259

Outpatient Worsening Heart Failure as a Target for Therapy A Review

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; VASODILATOR AGENT;

EID: 85043367484     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.5250     Document Type: Review
Times cited : (100)

References (67)
  • 1
    • 34447539951 scopus 로고    scopus 로고
    • Repeated hospitalizations predict mortality in the community population with heart failure
    • Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154(2):260-266.
    • (2007) Am Heart J. , vol.154 , Issue.2 , pp. 260-266
    • Setoguchi, S.1    Stevenson, L.W.2    Schneeweiss, S.3
  • 2
    • 70349907873 scopus 로고    scopus 로고
    • The heart failure frequent flyer: An urban legend
    • Mills RM. The heart failure frequent flyer: An urban legend. Clin Cardiol. 2009;32(2):67-68.
    • (2009) Clin Cardiol. , vol.32 , Issue.2 , pp. 67-68
    • Mills, R.M.1
  • 3
    • 84941621522 scopus 로고    scopus 로고
    • The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations
    • Nieminen MS, Dickstein K, Fonseca C, et al. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol. 2015;191:256-264.
    • (2015) Int J Cardiol. , vol.191 , pp. 256-264
    • Nieminen, M.S.1    Dickstein, K.2    Fonseca, C.3
  • 4
    • 84995363390 scopus 로고    scopus 로고
    • EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population
    • EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology
    • Nieminen MS, Brutsaert D, Dickstein K, et al; EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27 (22):2725-2736.
    • (2006) Eur Heart J. , vol.27 , Issue.22 , pp. 2725-2736
    • Nieminen, M.S.1    Brutsaert, D.2    Dickstein, K.3
  • 5
    • 54049105749 scopus 로고    scopus 로고
    • Transition from chronic compensated to acute decompensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures
    • Zile MR, Bennett TD, St John Sutton M, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118(14): 1433-1441.
    • (2008) Circulation , vol.118 , Issue.14 , pp. 1433-1441
    • Zile, M.R.1    Bennett, T.D.2    St John Sutton, M.3
  • 6
    • 84864241198 scopus 로고    scopus 로고
    • Rehospitalization for heart failure: Predict or prevent?
    • Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012; 126(4):501-506.
    • (2012) Circulation , vol.126 , Issue.4 , pp. 501-506
    • Desai, A.S.1    Stevenson, L.W.2
  • 7
    • 79955132796 scopus 로고    scopus 로고
    • Proportion of hospital readmissions deemed avoidable: A systematic review
    • vanWalraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: A systematic review. CMAJ. 2011;183(7):E391-E402.
    • (2011) CMAJ , vol.183 , Issue.7 , pp. E391-E402
    • Van Walraven, C.1    Bennett, C.2    Jennings, A.3    Austin, P.C.4    Forster, A.J.5
  • 8
    • 85029584953 scopus 로고    scopus 로고
    • Hospital-readmission risk-isolating hospital effects from patient effects
    • Krumholz HM, Wang K, Lin Z, et al. Hospital-readmission risk-isolating hospital effects from patient effects. N Engl J Med. 2017;377(11): 1055-1064.
    • (2017) N Engl J Med , vol.377 , Issue.11 , pp. 1055-1064
    • Krumholz, H.M.1    Wang, K.2    Lin, Z.3
  • 9
    • 84925868796 scopus 로고    scopus 로고
    • Certain uncertainty: Life after stroke from the patient's perspective
    • Hannah D, Lindholm B, Maisch L. Certain uncertainty: life after stroke from the patient's perspective. Circ Cardiovasc Qual Outcomes. 2014;7 (6):968-969.
    • (2014) Circ Cardiovasc Qual Outcomes , vol.7 , Issue.6 , pp. 968-969
    • Hannah, D.1    Lindholm, B.2    Maisch, L.3
  • 10
    • 84959564096 scopus 로고    scopus 로고
    • Assessment of home-time after acute ischemic stroke in Medicare beneficiaries
    • Fonarow GC, Liang L, Thomas L, et al. Assessment of home-time after acute ischemic stroke in Medicare beneficiaries. Stroke. 2016;47 (3):836-842.
    • (2016) Stroke , vol.47 , Issue.3 , pp. 836-842
    • Fonarow, G.C.1    Liang, L.2    Thomas, L.3
  • 11
    • 84870540437 scopus 로고    scopus 로고
    • Patients with acute heart failure in the emergency department: Do they all need to be admitted?
    • Pang PS, Jesse R, Collins SP, Maisel A. Patients with acute heart failure in the emergency department: do they all need to be admitted? J Card Fail. 2012;18(12):900-903.
    • (2012) J Card Fail , vol.18 , Issue.12 , pp. 900-903
    • Pang, P.S.1    Jesse, R.2    Collins, S.P.3    Maisel, A.4
  • 12
    • 84871912144 scopus 로고    scopus 로고
    • Is hospital admission for heart failure really necessary? the role of the emergency department and observation unit in preventing hospitalization and rehospitalization
    • Collins SP, Pang PS, Fonarow GC, Yancy CW, Bonow RO, Gheorghiade M. Is hospital admission for heart failure really necessary? the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J AmColl Cardiol. 2013;61(2):121-126.
    • (2013) J Am Coll Cardiol , vol.61 , Issue.2 , pp. 121-126
    • Collins, S.P.1    Pang, P.S.2    Fonarow, G.C.3    Yancy, C.W.4    Bonow, R.O.5    Gheorghiade, M.6
  • 13
    • 85027501384 scopus 로고    scopus 로고
    • Hospitalization for recently diagnosed versus worsening chronic heart failure: From the ASCEND-HF trial
    • Greene SJ, Hernandez AF, Dunning A, et al. Hospitalization for recently diagnosed versus worsening chronic heart failure: from the ASCEND-HF trial. J AmColl Cardiol. 2017;69(25): 3029-3039.
    • (2017) J Am Coll Cardiol , vol.69 , Issue.25 , pp. 3029-3039
    • Greene, S.J.1    Hernandez, A.F.2    Dunning, A.3
  • 14
    • 84907303502 scopus 로고    scopus 로고
    • Recognizing worsening chronic heart failure as an entity and an end point in clinical trials
    • Butler J, Braunwald E, Gheorghiade M. Recognizing worsening chronic heart failure as an entity and an end point in clinical trials. JAMA. 2014; 312(8):789-790.
    • (2014) JAMA , vol.312 , Issue.8 , pp. 789-790
    • Butler, J.1    Braunwald, E.2    Gheorghiade, M.3
  • 15
    • 34748819364 scopus 로고    scopus 로고
    • Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
    • Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators
    • Solomon SD, Dobson J, Pocock S, et al; Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116(13): 1482-1487.
    • (2007) Circulation , vol.116 , Issue.13 , pp. 1482-1487
    • Solomon, S.D.1    Dobson, J.2    Pocock, S.3
  • 16
    • 84871927704 scopus 로고    scopus 로고
    • Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: Correlation with outcomes
    • RELAX-AHF Investigators
    • Metra M, Cotter G, Davison BA, et al; RELAX-AHF Investigators. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J AmColl Cardiol. 2013;61(2):196-206.
    • (2013) J Am Coll Cardiol , vol.61 , Issue.2 , pp. 196-206
    • Metra, M.1    Cotter, G.2    Davison, B.A.3
  • 17
    • 59749099461 scopus 로고    scopus 로고
    • Acute heart failure syndromes
    • Gheorghiade M, Pang PS. Acute heart failure syndromes. J AmColl Cardiol. 2009;53(7):557-573.
    • (2009) J Am Coll Cardiol , vol.53 , Issue.7 , pp. 557-573
    • Gheorghiade, M.1    Pang, P.S.2
  • 18
    • 84899472608 scopus 로고    scopus 로고
    • Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT
    • Skali H, Dwyer EM, Goldstein R, et al. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT. Eur J Heart Fail. 2014;16 (5):560-565.
    • (2014) Eur J Heart Fail , vol.16 , Issue.5 , pp. 560-565
    • Skali, H.1    Dwyer, E.M.2    Goldstein, R.3
  • 19
    • 84964206619 scopus 로고    scopus 로고
    • Importance of clinical worsening of heart failure treated in the outpatient setting: Evidence from the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)
    • PARADIGM-HF Investigators and Committees
    • Okumura N, Jhund PS, Gong J, et al; PARADIGM-HF Investigators and Committees. Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Circulation. 2016;133(23):2254-2262.
    • (2016) Circulation , vol.133 , Issue.23 , pp. 2254-2262
    • Okumura, N.1    Jhund, P.S.2    Gong, J.3
  • 20
    • 84958830961 scopus 로고    scopus 로고
    • Temporal changes in postdischarge mortality risk after hospitalization for heart failure (from the EVEREST Trial)
    • Cook TD, Greene SJ, Kalogeropoulos AP, et al. Temporal changes in postdischarge mortality risk after hospitalization for heart failure (from the EVEREST Trial). Am J Cardiol. 2016;117(4):611-616.
    • (2016) Am J Cardiol , vol.117 , Issue.4 , pp. 611-616
    • Cook, T.D.1    Greene, S.J.2    Kalogeropoulos, A.P.3
  • 21
    • 84949537528 scopus 로고    scopus 로고
    • Serial high sensitivity cardiac troponin T measurement in acute heart failure: Insights from the RELAX-AHF study
    • Felker GM, Mentz RJ, Teerlink JR, et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail. 2015;17(12):1262-1270.
    • (2015) Eur J Heart Fail. , vol.17 , Issue.12 , pp. 1262-1270
    • Felker, G.M.1    Mentz, R.J.2    Teerlink, J.R.3
  • 22
    • 85045900865 scopus 로고    scopus 로고
    • Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: Findings from the ASTRONAUT trial
    • ASTRONAUT Investigators and Coordinators.[published online October 17, 2017
    • Greene SJ, Butler J, Fonarow GC, et al; ASTRONAUT Investigators and Coordinators. Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial [published online October 17, 2017]. Eur J Heart Fail. 2017.
    • (2017) Eur J Heart Fail
    • Greene, S.J.1    Butler, J.2    Fonarow, G.C.3
  • 23
    • 84878645318 scopus 로고    scopus 로고
    • Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients
    • Eapen ZJ, Liang L, Fonarow GC, et al. Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients. JACC Heart Fail. 2013;1(3):245-251.
    • (2013) JACC Heart Fail , vol.1 , Issue.3 , pp. 245-251
    • Eapen, Z.J.1    Liang, L.2    Fonarow, G.C.3
  • 24
    • 84995938203 scopus 로고    scopus 로고
    • Analysis of machine learning techniques for heart failure readmissions
    • Mortazavi BJ, Downing NS, Bucholz EM, et al. Analysis of machine learning techniques for heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2016;9(6):629-640.
    • (2016) Circ Cardiovasc Qual Outcomes , vol.9 , Issue.6 , pp. 629-640
    • Mortazavi, B.J.1    Downing, N.S.2    Bucholz, E.M.3
  • 25
    • 85017203403 scopus 로고    scopus 로고
    • Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: Comparison of machine learning and other statistical approaches
    • Frizzell JD, Liang L, Schulte PJ, et al. Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: comparison of machine learning and other statistical approaches. JAMA Cardiol. 2017;2(2):204-209.
    • (2017) JAMA Cardiol , vol.2 , Issue.2 , pp. 204-209
    • Frizzell, J.D.1    Liang, L.2    Schulte, P.J.3
  • 26
    • 29344440492 scopus 로고    scopus 로고
    • Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
    • ADHERE Scientific Advisory Committee and Investigators
    • Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J AmColl Cardiol. 2006;47(1):76-84.
    • (2006) J AmColl Cardiol. , vol.47 , Issue.1 , pp. 76-84
    • Yancy, C.W.1    Lopatin, M.2    Stevenson, L.W.3    De Marco, T.4    Fonarow, G.C.5
  • 27
    • 0016403662 scopus 로고
    • Cardiac decompensation
    • Ramírez A, Abelmann WH. Cardiac decompensation. N Engl J Med. 1974;290(9): 499-501.
    • (1974) N Engl J Med. , vol.290 , Issue.9 , pp. 499-501
    • Ramírez, A.1    Abelmann, W.H.2
  • 28
    • 84884294190 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines
    • Yancy CW, Jessup M, Bozkurt B, et al; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2013;62(16):e147-e239.
    • (2013) J Am Coll Cardiol , vol.62 , Issue.16 , pp. e147-e239
    • Yancy, C.W.1    Jessup, M.2    Bozkurt, B.3
  • 29
    • 14844291419 scopus 로고    scopus 로고
    • Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
    • ADHERE Scientific Advisory Committee and Investigators
    • Adams KF Jr, Fonarow GC, Emerman CL, et al; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2): 209-216.
    • (2005) Am Heart J. , vol.149 , Issue.2 , pp. 209-216
    • Adams, K.F.1    Fonarow, G.C.2    Emerman, C.L.3
  • 30
    • 84896961871 scopus 로고    scopus 로고
    • The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries
    • Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J AmColl Cardiol. 2014;63(12):1123-1133.
    • (2014) J Am Coll Cardiol , vol.63 , Issue.12 , pp. 1123-1133
    • Ambrosy, A.P.1    Fonarow, G.C.2    Butler, J.3
  • 31
    • 77950485827 scopus 로고    scopus 로고
    • The impact of early standard therapy on dyspnoea in patients with acute heart failure: The URGENT-dyspnoea study
    • Mebazaa A, Pang PS, Tavares M, et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: The URGENT-dyspnoea study. Eur Heart J. 2010;31(7): 832-841.
    • (2010) Eur Heart J. , vol.31 , Issue.7 , pp. 832-841
    • Mebazaa, A.1    Pang, P.S.2    Tavares, M.3
  • 32
    • 40649118759 scopus 로고    scopus 로고
    • Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study
    • COMPASS-HF Study Group
    • Bourge RC, Abraham WT, Adamson PB, et al; COMPASS-HF Study Group. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study. J AmColl Cardiol. 2008;51(11): 1073-1079.
    • (2008) J Am Coll Cardiol , vol.51 , Issue.11 , pp. 1073-1079
    • Bourge, R.C.1    Abraham, W.T.2    Adamson, P.B.3
  • 33
    • 77950884226 scopus 로고    scopus 로고
    • Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study
    • PARTNERS Study Investigators
    • Whellan DJ, Ousdigian KT, Al-Khatib SM, et al; PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J AmColl Cardiol. 2010;55(17): 1803-1810.
    • (2010) J Am Coll Cardiol , vol.55 , Issue.17 , pp. 1803-1810
    • Whellan, D.J.1    Ousdigian, K.T.2    Al-Khatib, S.M.3
  • 34
    • 79951850287 scopus 로고    scopus 로고
    • Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial
    • CHAMPION Trial Study Group
    • Abraham WT, Adamson PB, Bourge RC, et al; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet. 2011; 377(9766):658-666.
    • (2011) Lancet , vol.377 , Issue.9766 , pp. 658-666
    • Abraham, W.T.1    Adamson, P.B.2    Bourge, R.C.3
  • 35
    • 85019093819 scopus 로고    scopus 로고
    • Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in "real-world" clinical practice
    • Desai AS, Bhimaraj A, Bharmi R, et al. Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in "real-world" clinical practice. J AmColl Cardiol. 2017;69(19):2357-2365.
    • (2017) J Am Coll Cardiol , vol.69 , Issue.19 , pp. 2357-2365
    • Desai, A.S.1    Bhimaraj, A.2    Bharmi, R.3
  • 36
    • 84964766138 scopus 로고    scopus 로고
    • Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring
    • Costanzo MR, Stevenson LW, Adamson PB, et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Fail. 2016;4 (5):333-344.
    • (2016) JACC Heart Fail , vol.4 , Issue.5 , pp. 333-344
    • Costanzo, M.R.1    Stevenson, L.W.2    Adamson, P.B.3
  • 39
    • 77955466458 scopus 로고    scopus 로고
    • Improving evidence-based care for heart failure in outpatient cardiology practices: Primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)
    • Fonarow GC, Albert NM, Curtis AB, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122(6):585-596.
    • (2010) Circulation , vol.122 , Issue.6 , pp. 585-596
    • Fonarow, G.C.1    Albert, N.M.2    Curtis, A.B.3
  • 41
    • 84938289631 scopus 로고    scopus 로고
    • Thinking outside the box: Treating acute heart failure outside the hospital to improve care and reduce admissions
    • DeVore AD, Allen LA, Eapen ZJ. Thinking outside the box: Treating acute heart failure outside the hospital to improve care and reduce admissions. J Card Fail. 2015;21(8):667-673.
    • (2015) J Card Fail. , vol.21 , Issue.8 , pp. 667-673
    • DeVore, A.D.1    Allen, L.A.2    Eapen, Z.J.3
  • 42
    • 84951779726 scopus 로고    scopus 로고
    • Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit
    • Buckley LF, Carter DM, Matta L, et al. Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. JACC Heart Fail. 2016;4(1):1-8.
    • (2016) JACC Heart Fail , vol.4 , Issue.1 , pp. 1-8
    • Buckley, L.F.1    Carter, D.M.2    Matta, L.3
  • 43
    • 84928943057 scopus 로고    scopus 로고
    • The diuresis clinic: A new paradigm for the treatment of mild decompensated heart failure
    • Makadia S, Simmons T, Augustine S, et al. The diuresis clinic: A new paradigm for the treatment of mild decompensated heart failure. Am J Med. 2015;128(5):527-531.
    • (2015) Am J Med. , vol.128 , Issue.5 , pp. 527-531
    • Makadia, S.1    Simmons, T.2    Augustine, S.3
  • 44
    • 81955168095 scopus 로고    scopus 로고
    • Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program
    • Hebert K, Dias A, Franco E, Tamariz L, Steen D, Arcement LM. Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program. Congest Heart Fail. 2011;17(6):309-313.
    • (2011) Congest Heart Fail. , vol.17 , Issue.6 , pp. 309-313
    • Hebert, K.1    Dias, A.2    Franco, E.3    Tamariz, L.4    Steen, D.5    Arcement, L.M.6
  • 45
    • 0037181515 scopus 로고    scopus 로고
    • Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial
    • Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators
    • Cuffe MS, Califf RM, Adams KF Jr, et al; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA. 2002;287(12):1541-1547.
    • (2002) JAMA , vol.287 , Issue.12 , pp. 1541-1547
    • Cuffe, M.S.1    Califf, R.M.2    Adams, K.F.3
  • 46
    • 35848944656 scopus 로고    scopus 로고
    • Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials
    • VERITAS Investigators
    • McMurray JJ, Teerlink JR, Cotter G, et al; VERITAS Investigators. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials. JAMA. 2007;298(17):2009-2019.
    • (2007) JAMA , vol.298 , Issue.17 , pp. 2009-2019
    • McMurray, J.J.1    Teerlink, J.R.2    Cotter, G.3
  • 47
    • 77957730950 scopus 로고    scopus 로고
    • PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
    • Massie BM, O'Connor CM, Metra M, et al; PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010;363(15): 1419-1428.
    • (2010) N Engl J Med. , vol.363 , Issue.15 , pp. 1419-1428
    • Massie, B.M.1    O'Connor, C.M.2    Metra, M.3
  • 48
    • 79960090547 scopus 로고    scopus 로고
    • Effect of nesiritide in patients with acute decompensated heart failure
    • O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011; 365(1):32-43.
    • (2011) N Engl J Med , vol.365 , Issue.1 , pp. 32-43
    • O'Connor, C.M.1    Starling, R.C.2    Hernandez, A.F.3
  • 49
    • 84877960102 scopus 로고    scopus 로고
    • Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure
    • REVIVE Heart Failure Study Group
    • Packer M, Colucci W, Fisher L, et al; REVIVE Heart Failure Study Group. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013;1(2):103-111.
    • (2013) JACC Heart Fail. , vol.1 , Issue.2 , pp. 103-111
    • Packer, M.1    Colucci, W.2    Fisher, L.3
  • 50
    • 84871986523 scopus 로고    scopus 로고
    • Relaxin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial
    • Teerlink JR, Cotter G, Davison BA, et al; Relaxin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised, placebo-controlled trial. Lancet. 2013;381(9860):29-39.
    • (2013) Lancet , vol.381 , Issue.9860 , pp. 29-39
    • Teerlink, J.R.1    Cotter, G.2    Davison, B.A.3
  • 51
    • 85003914653 scopus 로고    scopus 로고
    • Rationale for and design of the TRUE-AHF trial: The effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure
    • TRUE-AHF Investigators and Committees
    • Packer M, Holcomb R, AbrahamWT, et al; TRUE-AHF Investigators and Committees. Rationale for and design of the TRUE-AHF trial: The effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. Eur J Heart Fail. 2017;19(5):673-681.
    • (2017) Eur J Heart Fail , vol.19 , Issue.5 , pp. 673-681
    • Packer, M.1    Holcomb, R.2    Abraham, W.T.3
  • 52
    • 33947713810 scopus 로고    scopus 로고
    • Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
    • Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
    • Konstam MA, Gheorghiade M, Burnett JC Jr, et al; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA. 2007;297(12): 1319-1331.
    • (2007) JAMA , vol.297 , Issue.12 , pp. 1319-1331
    • Konstam, M.A.1    Gheorghiade, M.2    Burnett, J.C.3
  • 53
    • 84875176312 scopus 로고    scopus 로고
    • Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial
    • ASTRONAUT Investigators and Coordinators
    • Gheorghiade M, Böhm M, Greene SJ, et al; ASTRONAUT Investigators and Coordinators. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial. JAMA. 2013;309(11):1125-1135.
    • (2013) JAMA , vol.309 , Issue.11 , pp. 1125-1135
    • Gheorghiade, M.1    Böhm, M.2    Greene, S.J.3
  • 54
    • 84949489402 scopus 로고    scopus 로고
    • Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: The SOCRATES-REDUCED randomized trial
    • SOCRATES-REDUCED Investigators and Coordinators
    • Gheorghiade M, Greene SJ, Butler J, et al; SOCRATES-REDUCED Investigators and Coordinators. Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: The SOCRATES-REDUCED randomized trial. JAMA. 2015;314(21):2251-2262.
    • (2015) JAMA , vol.314 , Issue.21 , pp. 2251-2262
    • Gheorghiade, M.1    Greene, S.J.2    Butler, J.3
  • 55
    • 85019456074 scopus 로고    scopus 로고
    • Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: Results of the Soluble Guanylate Cyclase Stimulator in Heart Failure Patients with PRESERVED EF (SOCRATES-PRESERVED) study
    • Pieske B, Maggioni AP, Lam CSP, et al. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the Soluble Guanylate Cyclase Stimulator in Heart Failure Patients with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J. 2017; 38(15):1119-1127.
    • (2017) Eur Heart J. , vol.38 , Issue.15 , pp. 1119-1127
    • Pieske, B.1    Maggioni, A.P.2    Lam, C.S.P.3
  • 56
    • 84901003001 scopus 로고    scopus 로고
    • Diuretic response in acute heart failure: Clinical characteristics and prognostic significance
    • Valente MAE, Voors AA, Damman K, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35(19):1284-1293.
    • (2014) Eur Heart J. , vol.35 , Issue.19 , pp. 1284-1293
    • Valente, M.A.E.1    Voors, A.A.2    Damman, K.3
  • 57
    • 84916618655 scopus 로고    scopus 로고
    • Diuretic response in patients with acute decompensated heart failure: Characteristics and clinical outcome-an analysis from RELAX-AHF
    • RELAX-AHF Investigators
    • Voors AA, Davison BA, Teerlink JR, et al; RELAX-AHF Investigators. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF. Eur J Heart Fail. 2014;16(11): 1230-1240.
    • (2014) Eur J Heart Fail , vol.16 , Issue.11 , pp. 1230-1240
    • Voors, A.A.1    Davison, B.A.2    Teerlink, J.R.3
  • 58
    • 84939568411 scopus 로고    scopus 로고
    • Diuretic response in acute heart failure-an analysis from ASCEND-HF
    • ter Maaten JM, Dunning AM, Valente MA, et al. Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J. 2015;170(2):313-321.
    • (2015) Am Heart J , vol.170 , Issue.2 , pp. 313-321
    • Ter Maaten, J.M.1    Dunning, A.M.2    Valente, M.A.3
  • 60
    • 1642568269 scopus 로고    scopus 로고
    • Diuretic effects of subcutaneous furosemide in human volunteers: A randomized pilot study
    • Verma AK, da Silva JH, Kuhl DR. Diuretic effects of subcutaneous furosemide in human volunteers: A randomized pilot study. Ann Pharmacother. 2004;38(4):544-549.
    • (2004) Ann Pharmacother , vol.38 , Issue.4 , pp. 544-549
    • Verma, A.K.1    Da Silva, J.H.2    Kuhl, D.R.3
  • 61
    • 80051959101 scopus 로고    scopus 로고
    • Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?
    • Zacharias H, Raw J, Nunn A, Parsons S, Johnson M. Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure? Palliat Med. 2011;25(6):658-663.
    • (2011) Palliat Med. , vol.25 , Issue.6 , pp. 658-663
    • Zacharias, H.1    Raw, J.2    Nunn, A.3    Parsons, S.4    Johnson, M.5
  • 62
    • 85039930352 scopus 로고    scopus 로고
    • Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure
    • published online November 27, 2017
    • Gilotra NA, Princewill O, Okwuosa IS, et al. Efficacy of intravenous furosemide versus a novel, pH-neutral furosemide formulation administered subcutaneously in outpatients with worsening heart failure [published online November 27, 2017]. JACC Heart Fail. doi:10.1016/j.jchf.2017.10.001.
    • JACC Heart Fail.
    • Gilotra, N.A.1    Princewill, O.2    Okwuosa, I.S.3
  • 63
    • 85019818217 scopus 로고    scopus 로고
    • Effect of ularitide on cardiovascular mortality in acute heart failure
    • TRUE-AHF Investigators
    • Packer M, O'Connor C, McMurray JJV, et al; TRUE-AHF Investigators. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med. 2017;376(20):1956-1964.
    • (2017) N Engl J Med , vol.376 , Issue.20 , pp. 1956-1964
    • Packer, M.1    O'Connor, C.2    McMurray, J.J.V.3
  • 64
    • 0034721244 scopus 로고    scopus 로고
    • Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
    • Nesiritide Study Group
    • Colucci WS, Elkayam U, Horton DP, et al; Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343(4):246-253.
    • (2000) N Engl J Med. , vol.343 , Issue.4 , pp. 246-253
    • Colucci, W.S.1    Elkayam, U.2    Horton, D.P.3
  • 65
    • 79551561121 scopus 로고    scopus 로고
    • Novel natriuretic peptides: New compounds and new approaches
    • Vogel MW, Chen HH. Novel natriuretic peptides: new compounds and new approaches. Curr Heart Fail Rep. 2011;8(1):22-27.
    • (2011) Curr Heart Fail Rep. , vol.8 , Issue.1 , pp. 22-27
    • Vogel, M.W.1    Chen, H.H.2
  • 66
    • 84956611096 scopus 로고    scopus 로고
    • Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure
    • McKie PM, Schirger JA, Benike SL, et al. Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure. Eur J Heart Fail. 2016;18(4):433-441.
    • (2016) Eur J Heart Fail. , vol.18 , Issue.4 , pp. 433-441
    • McKie, P.M.1    Schirger, J.A.2    Benike, S.L.3
  • 67
    • 84870239189 scopus 로고    scopus 로고
    • Novel protein therapeutics for systolic heart failure: Chronic subcutaneous B-type natriuretic peptide
    • Chen HH, Glockner JF, Schirger JA, Cataliotti A, Redfield MM, Burnett JC Jr. Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide. J AmColl Cardiol. 2012;60(22):2305-2312.
    • (2012) J AmColl Cardiol. , vol.60 , Issue.22 , pp. 2305-2312
    • Chen, H.H.1    Glockner, J.F.2    Schirger, J.A.3    Cataliotti, A.4    Redfield, M.M.5    Burnett, J.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.